ライフサイエンスコーパス: nanocapsule

1 CeO2, as well as the polymer coating alone (nanocapsule).

2 t step toward development of a biocompatible nanocapsule.

3 l disruption to the overall structure of the nanocapsule.

4 of discrete nickel-seamed pyrogallol[4]arene nanocapsules.

5 additional shell covalently connected to the nanocapsules.

6 terior as well as exterior properties of the nanocapsules.

7 lysis of dye-sensitized, lipid-vesicle based nanocapsules.

8 and specifically functionalized to generate nanocapsules.

9 chondrocytes which were pretreated with the nanocapsules.

10 l does not affect the fluorescence of poly A nanocapsules.

11 elf-assembles to form hierarchically ordered nanocapsules.

12 nterior of gallium-seamed pyrogallol[4]arene nanocapsules.

13 ht-induced release of DHEA from targeted DNA nanocapsules.

14 mechanisms into two different, well-defined nanocapsules: (1) pH-induced assembly yielded 28 nm viru

15 th Sleeping Beauty transposase in hyaluronan nanocapsules and injected them intravenously into hemoph

16 In the absence of human serum, nanocapsules and lipofectamine silenced expression of CC

17 The use of nanocapsules and related materials for drug delivery, as

18 idate the interplay between chondrocytes and nanocapsules and their therapeutic effect, we pursued a

19 teraction between adenine moieties of Poly A nanocapsules and thymine/uracil does not affect the fluo

20 solution, we can entrap charged molecules in nanocapsules and trigger the release of encapsulated con

21 ocytes did not show any adverse effects upon nanocapsule application and coherent anti-Stokes Raman s

22 The curcumin-conjugated nanocapsules are found to be spherical in size and their

23 Dye-loaded nanocapsules are immobilized in a polyvinyl alcohol (PVA

24 payload release from these plasmon resonant nanocapsules are independently controlled using a pulsed

25 ficiently functionalizing the core of hollow nanocapsules are scarce.

26 miRNA nanocapsules are synthesized with enhanced stability for

27 t to functional beverages, but protein-based nanocapsules are unstable around the isoelectric point o

28 n gold nanorod (AuNR)-encapsulated graphitic nanocapsule (AuNR@G), a photothermal agent, through pi-p

29 The aim of this study was to produce bixin nanocapsules by the interfacial deposition of preformed

30 These nanocapsules can be conjugated to different targeting li

31 These nanocapsules can be conjugated with curcumin.

32 During synthesis the nanocapsules can be loaded with hydrophobic small molecu

33 n the nanometer-thin shells of hollow porous nanocapsules can regulate the transport of charged molec

34 Particle deposition and nanocapsule clearance kinetics were measured by single p

35 , we show a novel delivery platform based on nanocapsules consisting of a protein core and a thin per

36 Redox-responsive nanocapsules consisting of conductive polyaniline and po

37 tudy has also demonstrated that CeO2 NPs and nanocapsules containing Nile red are able to traverse th

38 Nanocapsules containing these antioxidants were effectiv

39 is challenge, we present here a single siRNA nanocapsule delivery technology, which is achieved by en

40 of curcumin is improved dramatically in such nanocapsules demonstrating that nanotechnology could be

41 MS-DE or PDMS-DC) were encapsulated into the nanocapsules during the miniemulsion process and their r

42 tends the application of such bioluminescent nanocapsules, especially in deep tissue.

43 Notably, the nanocapsule exhibited a long circulation half-life of ~4

44 s studies on utilizing polymeric vesicles as nanocapsules, fabrication of tunable molecular pathways

45 and characterized self-assembling lipid-core nanocapsules for coencapsulation of two poorly soluble n

46 mes offers a promising functionality to tune nanocapsules for encapsulating and releasing fluorescent

47 hnology not only demonstrates the use of UOx nanocapsules for hyperuricemia management, but also prov

48 ing hyaluronan- and asialoorosomucoid-coated nanocapsules, generated using dispersion atomization, to

49 Interestingly, nanocapsules (>/= 800 mg/L) cause inhibition of hatch, a

50 the mechanism involved in the photolysis of nanocapsules has been opaque.

51 ork of nickel-seamed hexameric metal-organic nanocapsules has been synthesized by connecting the tail

52 e report self-assembled intertwining DNA-RNA nanocapsules (iDR-NCs) that efficiently delivered synerg

53 in we describe a nucleic acid functionalized nanocapsule in which nucleic acid ligands are assembled

54 reassembly could enable application of these nanocapsules in drug delivery and in nanomaterials synth

55 metal (Zn, Rb, or K) affords new trimetallic nanocapsules in solid state.

56 The monodisperse nanocapsules in the range of 50-200 nm consist of a dend

57 Rationally designed non-covalent protein nanocapsules incorporating copper-free "click chemistry"

58 ntalization of the indicator dyes within the nanocapsules increased their stability.

59 ternal cavity and sufficient dynamicity, the nanocapsule is able to recognize and encapsulate large a

60 de new functionality to the microcapsule and nanocapsule is layer-by-layer deposition of functional s

61 The nanocapsule is remarkably robust, being stable at low an

62 work shows that surface functionalization of nanocapsules is an effective and innovative method of co

63 luidic platform for the synthesis of complex nanocapsules is presented via a controlled self-assembly

64 In the presence of serum, CCR5-siRNA nanocapsules knocked down CCR5-mCherry expression to les

65 ed and/or expanded, that possess extra-large nanocapsule-like cages, high porosity, and potential for

66 Lipid nanocapsules (LNCs) are semi-rigid spherical capsules wi

67 The porous nanocapsule loaded films showed excellent stability and

68 combining a cell-targetable, icosahedral DNA-nanocapsule loaded with photoresponsive polymers, we sho

69 In this work, we utilized polymeric magnetic nanocapsules (m-NCs) for magnetic targeting in tumors an

70 Such nanocapsules maintain the integrity of siRNA inside even

71 -of-concept encapsulation of HRP through PSS nanocapsules may pave the way for alternative signal enh

72 report the use of stable magnetic graphitic nanocapsules (MGNs), for in situ targeted magnetic reson

73 nostics can be developed on the basis of the nanocapsule model described here.

74 d for hyperuricemia treatment, as-formed UOx nanocapsules, n(UOx), exhibits enhanced stability, more

75 Poly (D,L-lactide-coglycolide) nanocapsules (NC) were used to encapsulate 15d-PGJ(2).

76 Cl) embedded with an acid-responsive DNase I nanocapsule (NCa) was developed for targeted cancer trea

77 ramolecular engineering of water-dispersible nanocapsules (NCPs).

78 ssibility, we encapsulated HAs in lipid-core nanocapsules (NCs) based on a biodegradable and biocompa

79 This study investigated preparation of nanocapsules (NCs) containing food-grade ingredients usi

80 An original oral formulation of docetaxel nanocapsules (NCs) embedded in microparticles elicited i

81 The use of nanoparticle-stabilized nanocapsules (NPSCs) for the direct cytosolic delivery o

82 The self-assembly of the nanocapsule occurs such that the single resorcinol moiet

83 For 120-170 nm spherical LbL nanocapsules of low soluble anticancer drugs, polyelectr

84 Light-addressable nanocapsules offer a powerful method for delivering spat

85 d the photothermal effects of ICG containing nanocapsules on EGFR-rich tumor cells.

86 ammation affects the clearance of 50nm lipid nanocapsules, or is exacerbated by their pulmonary admin

87 different biomaterial types, pegylated lipid nanocapsules, polyvinyl acetate (PVAc) and polystyrene n

88 These nanocapsules possess greatly enhanced stability, retaine

89 Despite the diversity of methods for nanocapsule preparation, methods for efficiently functio

90 tor dyes were entrapped in vesicle-templated nanocapsules prepared by copolymerization of tert-butyl

91 ied to more than 500% in curcumin-conjugated nanocapsules prepared from the above procedure.

92 antibody adsorbed onto the PSS shell of the nanocapsules provided the recognition molecule.

93 Treatment with nanocapsules resulted in a major reduction of nitric oxi

94 The porous nanocapsules retain molecules larger than the pore size

95 mplete seam of coordination bonds around the nanocapsule's typically octa-metalated belt.

96 LHRH-conjugated nanocapsules selectively delivered recombinant human tum

97 s, manipulation, and assembling of plasmonic nanocapsule SERS sensors for high-sensitivity biochemica

98 given quantity of antibody, the bioconjugate nanocapsules showed 30 times greater sensitivity and a s

99 These nanocapsules showed improved photolysis efficiency over

100 The silica-coated magnetic nanocapsules (SiMNCs) allow on-demand drug release via r

101 vourable colloidal properties), silica-based nanocapsules (SNCs) with a size cutoff of approximately

102 on methylcellulose (MC) and alpha-tocopherol nanocapsule suspension (NCs) were developed.

103 re, we report the discovery of a enantiopure nanocapsule that is formed through the self-assembly of

104 Vaults are self-assembled ribonucleoprotein nanocapsules that consist of multiple copies of three pr

105 into the system resulted in the formation of nanocapsules that were cleaved under specific conditions

106 Individual components enter hollow nanocapsules through nanopores in the capsule shell.

107 ffraction structure of a dimeric zinc-seamed nanocapsule using a mixed pyrogallol/resorcinol[4]arene

108 this information, we were able to design new nanocapsules using ternary mixtures of lipid and cholest

109 interior of metal-organic pyrogallol[4]arene nanocapsules via aqueous "gates".

110 cavitands were shown to form supramolecular nanocapsules via assembly around a range of guest molecu

111 The average size of nanocapsule was in a range 150-400 nm.

112 oxygen sensors, encapsulation into oily core nanocapsules was performed.

113 und 100% of encapsulation efficiency and the nanocapsules were considered physically stable during 11

114 silencing target of HIV therapy, CCR5-siRNA nanocapsules were delivered into 293T cells and successf

115 Bioconjugate nanocapsules were fabricated by using polystyrene sulfon

116 earance and whole body distribution of lipid nanocapsules were unaffected by the presence of acute lu

117 nitroxide was incarcerated into an octa acid nanocapsule, which was confirmed by 1H NMR and EPR spect

118 e siRNA molecule within a degradable polymer nanocapsule with a diameter around 20 nm and positive su

119 Polymeric nanocapsules with cross-linked shells and the latent azi

120 amines in the polymerization, we endowed the nanocapsules with efficient cell-transduction and suffic

121 In addition, functionalization of nanocapsules with multiple pyridine molecules at the cap

122 Dyes are entrapped in hollow nanocapsules with nanometer-thin walls of controlled por

123 ion with chloroauric acid, forming graphitic nanocapsules with significant surface-enhanced Raman sig

124 nyl groups, we obtained nanosized core-shell nanocapsules with the enzyme as the core and a cross-lin